Lumen Bioscience, Inc.
Clinical trials sponsored by Lumen Bioscience, Inc., explained in plain language.
-
New drug aims to break the cycle of recurring c. diff infections
Prevention Recruiting nowThis study tests an experimental drug called LMN-201 to see if it can prevent C. difficile infections from returning after standard antibiotic treatment. About 375 adults with a recent C. diff infection will receive either LMN-201 or a placebo. The main goal is to see if more peo…
Phase: PHASE2, PHASE3 • Sponsor: Lumen Bioscience, Inc. • Aim: Prevention
Last updated May 11, 2026 20:41 UTC
-
Aussie tummy troubles: study tracks diarrhea causes in southeast asia travelers
Knowledge-focused Recruiting nowThis study will track 1,200 Australian adults traveling to Southeast Asia to see how often they get travelers' diarrhea and what germs cause it. Participants will report symptoms via smartphone and may provide stool samples. Results will help plan future trials for better prevent…
Sponsor: Lumen Bioscience, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC